BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28803622)

  • 21. 3.0 T prostate MRI: Visual assessment of 2D and 3D T2-weighted imaging sequences using PI-QUAL score.
    Brillat-Savarin N; Wu C; Aupin L; Thoumin C; Hamzaoui D; Renard-Penna R
    Eur J Radiol; 2023 Sep; 166():110974. PubMed ID: 37453273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?
    Huebner NA; Korn S; Resch I; Grubmüller B; Gross T; Gale R; Kramer G; Poetsch N; Clauser P; Haitel A; Fajkovic H; Shariat SF; Baltzer PA
    Eur Radiol; 2021 Jun; 31(6):3754-3764. PubMed ID: 33263793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences.
    Bura V; Caglic I; Snoj Z; Sushentsev N; Berghe AS; Priest AN; Barrett T
    Eur Radiol; 2021 Jul; 31(7):4908-4917. PubMed ID: 33398421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI.
    Almansour H; Afat S; Fritz V; Schick F; Nachbar M; Thorwarth D; Zips D; Müller AC; Nikolaou K; Othman AE; Wegener D
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aperistaltic effect of hyoscine N-butylbromide versus glucagon on the small bowel assessed by magnetic resonance imaging.
    Froehlich JM; Daenzer M; von Weymarn C; Erturk SM; Zollikofer CL; Patak MA
    Eur Radiol; 2009 Jun; 19(6):1387-93. PubMed ID: 19190916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
    Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
    Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
    Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
    Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small Field-of-view single-shot EPI-DWI of the prostate: Evaluation of spatially-tailored two-dimensional radiofrequency excitation pulses.
    Attenberger UI; Rathmann N; Sertdemir M; Riffel P; Weidner A; Kannengiesser S; Morelli JN; Schoenberg SO; Hausmann D
    Z Med Phys; 2016 Jun; 26(2):168-76. PubMed ID: 26300045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of deep learning-based reconstruction on T2-weighted and diffusion-weighted prostate MRI image quality.
    Lee KL; Kessler DA; Dezonie S; Chishaya W; Shepherd C; Carmo B; Graves MJ; Barrett T
    Eur J Radiol; 2023 Sep; 166():111017. PubMed ID: 37541181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-to-high b value DWI ratio approaches in multiparametric MRI of the prostate: feasibility, optimal combination of b values, and comparison with ADC maps for the visual presentation of prostate cancer.
    Xi Y; Liu A; Olumba F; Lawson P; Costa DN; Yuan Q; Khatri G; Yokoo T; Pedrosa I; Lenkinski RE
    Quant Imaging Med Surg; 2018 Jul; 8(6):557-567. PubMed ID: 30140618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiparametric MRI Features and Pathologic Outcome of Wedge-Shaped Lesions in the Peripheral Zone on T2-Weighted Images of the Prostate.
    Chatterjee A; Tokdemir S; Gallan AJ; Yousuf A; Antic T; Karczmar GS; Oto A
    AJR Am J Roentgenol; 2019 Jan; 212(1):124-129. PubMed ID: 30403532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-resolution T2-weighted abdominal magnetic resonance imaging using respiratory triggering: impact of butylscopolamine on image quality.
    Wagner M; Klessen C; Rief M; Elgeti T; Taupitz M; Hamm B; Asbach P
    Acta Radiol; 2008 May; 49(4):376-82. PubMed ID: 18415778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images.
    Abd-Alazeez M; Ramachandran N; Dikaios N; Ahmed HU; Emberton M; Kirkham A; Arya M; Taylor S; Halligan S; Punwani S
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):128-36. PubMed ID: 25644248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate magnetic resonance imaging at 3 Tesla: Is administration of hyoscine-N-butyl-bromide mandatory?
    Roethke MC; Kuru TH; Radbruch A; Hadaschik B; Schlemmer HP
    World J Radiol; 2013 Jul; 5(7):259-63. PubMed ID: 23908696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiparametric MRI of the prostate with three functional techniques in patients with PSA elevation before initial TRUS-guided biopsy.
    Hauth E; Hohmuth H; Cozub-Poetica C; Bernand S; Beer M; Jaeger H
    Br J Radiol; 2015 Oct; 88(1054):20150422. PubMed ID: 26268144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
    Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
    Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T1 mapping of the prostate using Single-Shot T1FLASH and MOLLI MRI Techniques: Comparison of artifact burden and image quality.
    Al-Bourini O; Seif Amir Hosseini A; Biggemann L; Uhlig A; Balz J; Haas L; Voit D; Lotz J; Frahm J; Uhlig J
    Eur J Radiol; 2023 May; 162():110783. PubMed ID: 36966698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of suspected soft tissue lesion in the prostate bed after radical prostatectomy using 3T multiparametric magnetic resonance imaging.
    Cha D; Kim CK; Park SY; Park JJ; Park BK
    Magn Reson Imaging; 2015 May; 33(4):407-12. PubMed ID: 25527395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.